Mr. Joshua Tollison Bishop, PA-C Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 205 Howard Ave, Mullens, WV 25882 Phone: 304-294-4880 |
News Archive
NexMed, Inc., a specialty CRO with a pipeline of products based on the NexACT® technology, today announced that the U.S. Food & Drug Administration (FDA) has cleared the Company to proceed with the proposed Phase 2 trial of PrevOnco™, its proprietary cancer treatment for patients with advanced, unresectable hepatocellular carcinoma (HCC), or liver cancer. The FDA granted PrevOnco™ orphan drug status in August 2008, and in March 2010, NexMed filed its Investigational New Drug (IND) application for the product candidate.
According to study results released this Monday, women with a close relative with breast cancer may not be at a higher risk of getting breast cancer. The findings may bring comfort to women from high-risk families after a 2007 study suggested that simply having a relative with a BRCA1 or BRCA2 mutation raised their risk of developing breast cancer, even if they had tested negative for the genes.
Ever gone to the movies and forgotten where you parked the car? New UCLA research may one day help you improve your memory.
Twenty-two facilities in the Midwest have been named Centers of Excellence in accelerated partial breast irradiation (APBI) for their use of the SAVI® applicator, an advanced therapy for breast cancer as part of breast conservation therapy. The SAVI applicator can provide important advantages for women with early-stage breast cancer.
Researchers from the Harvard Medical School-affiliated Hebrew SeniorLife Institute for Aging Research, in collaboration with scientists from Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, Brown University, and Northeastern University, have discovered that postoperative delirium negatively impacts recovery in older adults.
› Verified 1 days ago